Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TScan Therapeutics (TCRX) Prepaid Assets (2020 - 2025)

TScan Therapeutics (TCRX) has disclosed Prepaid Assets for 6 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 83.84% to $4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, up 83.84% year-over-year, with the annual reading at $4.8 million for FY2025, 83.84% up from the prior year.
  • Prepaid Assets for Q4 2025 was $4.8 million at TScan Therapeutics, up from $3.7 million in the prior quarter.
  • The five-year high for Prepaid Assets was $5.3 million in Q1 2023, with the low at $1.4 million in Q2 2023.
  • Average Prepaid Assets over 5 years is $3.4 million, with a median of $3.7 million recorded in 2025.
  • The sharpest move saw Prepaid Assets skyrocketed 156.89% in 2021, then tumbled 63.43% in 2024.
  • Over 5 years, Prepaid Assets stood at $4.2 million in 2021, then decreased by 3.51% to $4.1 million in 2022, then plummeted by 46.51% to $2.2 million in 2023, then grew by 19.11% to $2.6 million in 2024, then soared by 83.84% to $4.8 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $4.8 million, $3.7 million, and $3.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.